NCI's RAS Initiative explores revolutionary techniques for attacking the proteins encoded by mutant types of the KRAS gene. A few other KRAS G12C inhibitors are about the heels of sotorasib and they are at the moment being tested in medical trials. And there are actually very likely more to return. https://derrickc332qbl5.hyperionwiki.com/user